Researchers in Italy have published results showing mild symptoms in 223 out of 232 (96%) of people with MS who had suspected or confirmed COVID-19.
57 of the 232 people with suspected COVID-19 had it confirmed with a test. Within the 57 people with confirmed COVID-19:
- 4 people (2% of everyone in the study) had severe symptoms
- 6 people were critical (3% of everyone in the study). Of the 6 critical patients, 1 person recovered and 5 died.
The results are very early but suggest current disease modifying therapy (DMT) and shielding advice for people with MS is correct.
Take part in MS and coronavirus research
We need you to add to the data we're collecting to understand the impact of coronavirus on people with MS in the UK.
We’re supporting the UK MS Register to run a survey looking at how COVID-19 is affecting people with MS.
Your answers help us give the most up-to-date advice on shielding and DMTs. And keep making the case with the government and NHS for the care and support our community needs.
A global MS research effort to understand COVID-19
Many MS organisations across the world are also gathering data on how people with MS are affected by the outbreak.
Multiple Sclerosis International Federation (MSIF) is backing a global data sharing initiative to bring this information together. Together we can build a better picture of how the pandemic is affecting the MS community around the world.
You can help by taking the MS Register survey today.
The Italian study group on COVID-19 in MS paper
We're here for you
If you want to talk about anything in this article, our MS Helpline is here with emotional support and information for everyone living with MS. The lines are open Monday to Friday, 9am to 7pm except bank holidays. Call freephone 0808 800 8000 or email [email protected]
Find information webinars, ways to connect with other people in our community and ideas to keep you busy in lockdown on our Never Alone hub page